545 related articles for article (PubMed ID: 19321933)
1. Novel drug delivery systems for retinal diseases. A review.
Lee SS; Robinson MR
Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery methods for posterior segment disease.
Hsu J
Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
[TBL] [Abstract][Full Text] [Related]
3. Medical devices for the treatment of eye diseases.
Yasukawa T; Ogura Y
Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
5. Transport barriers in transscleral drug delivery for retinal diseases.
Kim SH; Lutz RJ; Wang NS; Robinson MR
Ophthalmic Res; 2007; 39(5):244-54. PubMed ID: 17851264
[TBL] [Abstract][Full Text] [Related]
6. The use of intraocular corticosteroids.
Kiernan DF; Mieler WF
Expert Opin Pharmacother; 2009 Oct; 10(15):2511-25. PubMed ID: 19761356
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal steroids for macular edema: the past, the present, and the future.
Cunningham MA; Edelman JL; Kaushal S
Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
[TBL] [Abstract][Full Text] [Related]
8. Treatment of retinal diseases with VEGF antagonists.
Schlingemann RO; Witmer AN
Prog Brain Res; 2009; 175():253-67. PubMed ID: 19660661
[TBL] [Abstract][Full Text] [Related]
9. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in drug delivery systems for treating ocular complications of systemic diseases.
Lee SS; Hughes PM; Robinson MR
Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987
[TBL] [Abstract][Full Text] [Related]
11. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Ranta VP; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal pharmacotherapy: applications in retinal disease.
Prasad AG; Schadlu R; Apte RS
Compr Ophthalmol Update; 2007; 8(5):259-69. PubMed ID: 18201513
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of therapeutic agents.
Peyman GA; Lad EM; Moshfeghi DM
Retina; 2009; 29(7):875-912. PubMed ID: 19584648
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery systems for vitreoretinal diseases.
Yasukawa T; Ogura Y; Tabata Y; Kimura H; Wiedemann P; Honda Y
Prog Retin Eye Res; 2004 May; 23(3):253-81. PubMed ID: 15177203
[TBL] [Abstract][Full Text] [Related]
17. Monitoring ocular drug therapy by analysis of aqueous samples.
Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
[TBL] [Abstract][Full Text] [Related]
18. [Retina and glaucoma: therapeutic considerations].
Aptel F; Denis P
J Fr Ophtalmol; 2008 Jul; 31(6 Pt 2):2S61-4. PubMed ID: 18957916
[TBL] [Abstract][Full Text] [Related]
19. Delivery of anti-angiogenic molecular therapies for retinal disease.
Anderson OA; Bainbridge JW; Shima DT
Drug Discov Today; 2010 Apr; 15(7-8):272-82. PubMed ID: 20184967
[TBL] [Abstract][Full Text] [Related]
20. Intraocular sustained drug delivery using implantable polymeric devices.
Yasukawa T; Ogura Y; Sakurai E; Tabata Y; Kimura H
Adv Drug Deliv Rev; 2005 Dec; 57(14):2033-46. PubMed ID: 16263193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
